baber/WOPTO huggingface dataset:
Patent JP-2001512615-A (JP)
Title: 最尤度検出のための方法及び装置
IPC: G11B20/10
Filed: 1998-10-29
Abstract: (57)【要約】
光学読出しチャネルからデータを回復する方法及び装置は、低い位相及び振幅の余裕を許容することにより改善された記録密度を与える。方法は、第１の信号の複数のサンプルをディジタル化する段階と、第１の信号のディジタル化されたサンプルをクリッピングする段階と、クリッピングされディジタル化されたサンプルをディジタル式に微分する段階と、信号極性変化の相対的な位置を決定する段階と、少なくとも部分的に信号極性変化の相対的な位置に基づいてチャネルビットの論理値を発生する段階とを含む。光学読出しチャネルからデータを回復する装置は、信号レベルリミッタと、信号レベルリミッタに結合されるディジタル微分器と、ディジタル微分器に結合される最大／最小検出器と、ディジタル微分器に結合されるゼロ交差検出器と、ゼロ交差検出器及び最大／最小検出器に結合される更新信号発生器と、チャネルビット遷移発生器とを含む。
Patent JP-2000507335-A (JP)
Title: スピンドルモーター用の能動電磁減衰システム
IPC: F16C39/06
Filed: 1997-03-19
Abstract: (57)【要約】
回転システムの共振を減衰する方法を開示しており、同方法は、回転システム中の振動運動を表す式の展開、同式からの導関数の採用、運動を減衰させるため導関数に基づき位相のずれた能動的な減衰力を回転システムに加えることを含んでいる。
Patent JP-2000507569-A (JP)
Title: 抗精神病薬ならびに鎮痛薬を製造するための、１，１―ジアルキル―１，２，３，４―テトラヒドロイソキノリンの使用
IPC: A61P25/18
Filed: 1997-03-28
Abstract: (57)【要約】
次式(Ｉ)：
 （式中、Ｒ 1 およびＲ 2 は、それぞれ独立して、低級アルキル基を表す。）で示される１，１−ジアルキル−１，２，３，４−テトラヒドロイソキノリンまたはその薬理学的に許容される塩を有効成分とする抗精神病薬に関し、ドパミンＤ 2 受容体遮断作用に基づく抗精神病作用、ならびにモルヒネ様の依存性のない鎮痛作用を示すものである。
Patent JP-H11509237-A (JP)
IPC: C07D401/04
Filed: 1997-04-30
Abstract: PCT No. PCT/KR97/00073 Sec. 371 Date Oct. 21, 1998 Sec. 102(e) Date Oct. 21, 1998 PCT Filed Apr. 30, 1997 PCT Pub. No. WO97/42186 PCT Pub. Date Nov. 13, 1997The present invention relates to a process for preparation of 5,6-dimethyl-2-(4-fluorophenyl-amino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine represented by the following formula (I), and its acid addition salts by reacting a pyrimidine derivative represented by the formula (II-A), in which Hal represents a halogen, with 1-methyl-1,2,3,4-tetrahydroisoquinoline represented by the formula (III),
Patent JP-2000510639-A (JP)
Title: 温度安定性誘電率を有するポリマー組成物
IPC: H05K1/16
Filed: 1997-05-07
Abstract: (57)【要約】
温度によって殆ど変化しない高い誘電率を有するポリマー組成物を、熱可塑性ポリマー、１．０ＧＨｚ及び２０℃において少なくとも約５０の誘電率を有する高誘電性セラミック、及び、１．０ＧＨｚ及び２０℃において少なくとも約５の誘電率を有する第２のセラミック材料から製造し、高誘電性セラミック及び第２のセラミック材料は、互いに正負が反対の温度係数を有する。
Patent JP-2001510598-A (JP)
Title: コンピュータ・ファイルにアクセスするためのデバイス駆動装置
IPC: G06F17/30
Filed: 1997-05-08
Abstract: (57)【要約】
記憶装置においてアーカイブに保持された圧縮されたファイルにアクセスするためのコンピュータ・デバイス駆動装置であって、記憶装置内のアーカイブから圧縮されたファイルを読出し、ファイルをＲＡＭ内で圧縮解除し、該圧縮解除されたファイルをＲＡＭに全部又は一部保持する手段を備え、そのため圧縮解除されたファイルを記憶装置に最初に書き込む必要なしに記憶装置に対するオペレーションがオペレーティング・システムにより圧縮されたファイルについて実行されることができるコンピュータ・デバイス駆動装置である。該駆動装置はまた、前記ＲＡＭ内のファイルにアクセスし、ファイルの内容を変え、且つファイルを前記記憶装置内のアーカイブに戻す手段も備える。
Patent JP-2001519090-A (JP)
Title: バイポーラトランジスタ構造
IPC: H01L27/12
Filed: 1998-03-19
Abstract: (57)【要約】
バイポーラトランジスタにおいて熱的暴走を避けるため、エミッタに安定抵抗器が設けられる。延長した安定抵抗器を用いて、その長さの部分を適当な抵抗と設計の融通性が得られるように接続することが提案される。１つの態様において、エミッタ（３）を複数のエミッタ部分に分割し、各部分に分離されたエミッタ安定抵抗器を設けることが提案される。好ましい実施例においては、コレクタとベースは対応的に分割され、トランジスタは複数の単位セルに分割され、各単位セルがエミッタ、安定抵抗器、ベースおよびコレクタを含み、それぞれ共通導線（１０、１１、１２）を介して接続される。この構成はＳＯＩ技術により好適に実現され、直流的隔離によりデジタル、アナログおよび電力装置を１つのチップ上に問題なく組み合わすことを可能とする。
Patent JP-2002511060-A (JP)
Title: ホスホジエステルを合成するためのプロセス
IPC: C07F9/09
Filed: 1998-01-27
Abstract: (57)【要約】
式(I)を有するホスホジエステル化合物の生成のための改良されたプロセス。これらの化合物は画像診断法のための造影剤として特に有用である。このプロセスは、複数の中間体の形成により還元されることを防ぐための複数の単離および精製の工程の必要性を、回避する。
Patent JP-2001522358-A (JP)
Title: 高純度６，７−ジクロロ−５−ニトロ−２，３−ジヒドロキノキサリン−２，３−ジオンの調製方法
IPC: C07D241/44
Filed: 1998-04-20
Abstract: (57)【要約】
本発明は、粗６，７−ジクロロ−５−ニトロ−２，３−ジヒドロキノキサリン−２，３−ジオンを高極性溶媒および水の溶液から再結晶させることを含む、高純度６，７−ジクロロ−５−ニトロ−２，３−ジヒドロキノキサリン−２，３−ジオンの製造方法を提供する。
Patent JP-2001527416-A (JP)
IPC: G01N33/569
Filed: 1998-05-18
Abstract: The present invention is based upon the finding that porcine endogenous retroviruses exist in two different subtypes, which we have termed PERV-A and PERV-B. The differences are reflected in sequence divergence in the envelope genes, and these differences may be used to provide nucleic acid and antibody probes which can distinguish between the two subtypes. This allows patterns of subtype transmission between cells, particularly porcine to human cells, to be monitored.
Patent JP-2002502241-A (JP)
IPC: C12N15/45
Filed: 1998-05-22
Abstract: Isolated polynucleotide molecules provide recombinant PIV genomes and antigenomes for production of recombinant PIV vaccines. The recombinant genome or antigenome can be expressed with a nucleoprotein (N), phosphoprotein (P), and a large (L) polymerase protein to produce isolated infectious PIV particles. The recombinant PIV genome and antigenome can be modified to produce desired changes, for example to incorporate attenuating mutations from biologically derived PIV mutants or to create chimeric PIV clones, to generate attenuated, immunogenic viruses for vaccine use.
Patent JP-2002505624-A (JP)
Title: 部品搬送装置
IPC: B65G47/91
Filed: 1999-04-15
Abstract: (57)【要約】
本発明は、部品搬送装置の部品搬送用ヘッドに用いる真空式ピックアップノズル(6)に関するものである。このピックアップノズルにより、プリント回路板上に配置する部品(9)を、吸引力によってピックアップし、かつ保持することが可能である。一つのノズルでピックアップできる部品の範囲を増加させるために、ノズル開口部(12)に、動作時に異なる大きさの部品(9,9a,9b,9c)を吸い込みかつ保持可能とする通気性を有するカバーを設ける。
Patent MX-155914-A (MX)
Inventor: OOMS JULIUS
IPC: C11D1/835
Filed: 1982-03-05
Abstract: Concentrated textile treatment compositions suitable for use in the rinse cycle of a textile laundering operation containing from 12% to 25% of an active mixture comprising a water-insoluble quaternary ammonium fabric softener, a water-soluble alkoxylated ammonium surfactant and a fatty acid ester of a polyhydric alcohol. The compositions are stable dispersions displaying excellent viscosity characteristics at both low and high temperature over prolonged periods of storage.
Patent NZ-202614-A (NZ)
Title: Producing liquid-solid metal alloy by extrusion
Inventor: BUSK R S
IPC: C22C1/00
Filed: 1982-11-25
Abstract: A process for forming a liquid-solid composition from a material which, when frozen from its liquid state without agitation, forms a dendritic structure. A material having a non-thixotropic-type structure, in a solid form, is fed into an extruder. The material is heated to a temperature above its liquidus temperaure. It is then cooled to a temperature less than its liquidus temperature and greater than its solidus temperature, while being subjected to sufficient shearing action to break at least a portion of the dendritic structures as they form. Thereafter, the material is fed out of the extruder.
Patent NZ-222011-A (NZ)
Title: Layered meat emulsion product
Inventor: MARTIN R C
IPC: A23L13/40
Filed: 1987-10-01
Abstract: A meat emulsion containing meat, meat by-products, water and one or more dry proteinaceous materials is prepared, with the emulsion having a protein to fat ratio of at least about 1.5:1 and a moisture content in the range of about 45% to 80%. The hot meat emulsion is introduced by centrifugal force into a confined holding tube in which the emulsion is retained for a relatively short period of time during which the protein coagulates to set the emulsion and provide a firm meat emulsion product, with the emulsion being maintained at a pressure greater than the vapor pressure of emulsion water. When the protein has coagulated sufficiently to form a firm emulsion, the emulsion pressure is reduced below the vapor pressure of the emulsion water so that water in the emulsion is vaporized, and pressurized steam is periodically injected into the emulsion mass. The effect of the combination of pumping the hot emulsion into the holding tube by centrifugal force, subjecting the confined emulsion to steam pressure while the protein is rapidly coagulating, together with pressure exerted on the emulsion, provide a set meat emulsion product having a plurality of distinct emulsion layers which are bonded together, and the layered product is discharged from the holding tube in the form of discrete pieces or chunks. Such layered meat emulsion chunks may be used for human consumption or for consumption by pet animals, depending on the nature and quality of the meat materials used.
Patent NZ-227443-A (NZ)
Title: Protective helmet: impact separation of liner from shell
Inventor: COOMBS CHRISTOPHER E
IPC: A42B3/00
Filed: 1988-12-21
Abstract: There is disclosed an improved protective helmet assembly (10) including an outer shell (12) and an inner impact attenuation liner assembly (14) wherein a chinstrap assembly (22) is mounted to the inner impact attenuation liner assembly (14) and the inner impact attenuation liner assembly (14) is mounted within the outer impact shell (12) to detach under predetermined load conditions from the outer impact shell (12).
Patent NZ-229868-A (NZ)
Title: Log-polar signal processing
Inventor: DENT PAUL WILKINSON
IPC: H04L27/22
Filed: 1989-07-07
Abstract: The invention relates to a method and an arrangement intended for radio communication systems and effective in digitalizing and subsequently processing numerically arbitrary radio signals. The signals are represented by composite (complex) vectors which have been subjected to disturbances in the system, such that information in the signals has been lost. This information is restored in its entirety when practising the present invention. For the purpose of solving this problem, the inventive digitalizing arrangement includes a multistage logarithmic amplifier chain (A) in which each stage is connected to a separate detector (D), the output signals of which are added in an adder. The adder output signals are then transmitted to a first A/D-converter (AD1) for digitalizing and converting the amplitude components of the signal. At the same time, the undetected signal from the saturated output stage in the amplifier chain is transmitted to a second A/D-converter for digitalizing and converting the phase components of the signal. The digital values obtained on the outputs of the AD-converters (AD1, AD2) are applied to different inputs of a digital signal processor (MP) for numerical processing of the pairwise received digital values in a manner such as to restore the complete vector characteristic of the signal.
Patent NZ-230672-A (NZ)
Title: 4-(4-(3-benzoisothiazolyl)-1-piperazinyl) butyl azabicycloalkanes and pharmaceutical compositions
Inventor: BRIGHT GENE MICHAEL
IPC: C07D417/14
Filed: 1989-09-15
Abstract: 4-(4-(3-Benzisothiazolyl)-1-piperazinyl)butyl bridged bicyclic imides of formula (I) and their pharmaceutically acceptable acid addn. salts are new: R1R2=H, Me, Et X=-CH2-, -CH2CH2-, -CH2CH2CH2- Y = CR3R4 R3, R4 = H, Me .
Patent NZ-231084-A (NZ)
Title: Forming metal matrix composite by spontaneous infiltration of a matrix metal into a non reactive filler
Inventor: NAGELBERG ALAN SCOTT
IPC: C04B41/88
Filed: 1989-10-19
Abstract: The present invention relates to the formation of a metal matrix composite body by a spontaneous infiltration technique. Particularly, an infiltration enhancer and/or infiltration enhancer precursor can be positioned at least partially between or at an interface between a matrix metal (2) and a filler material (3) (or preform) which is to be infiltrated by molten matrix metal (2). Moreover, at least at some point during the process, an infiltrating atmosphere may be in communication with the filler material or preform (3) and/or matrix metal (2).
Patent NZ-232350-A (NZ)
Title: N-(1-methyl-3-((halophenoxy)phenyl)prop-2-en-1-yl)-n-hydroxyurea derivatives and pharmaceutical compositions
Inventor: JACKSON WILLIAM PAUL
IPC: A61P7/02
Filed: 1990-02-02
Abstract: The present inventions concerned with compounds of formula (I) <CHEM>  wherein  Ar is 4-halophenyl;  Ar min  is 1,3- or 1,4-phenylene;  Y is (E)-CH=CH-; and R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; and base salts and physiologically functional derivatives thereof, processes for their preparation, pharmaceutical formulations containing them and, optionally, one or more other pharmacologically active ingredients and the use of these compounds in medicine.
Patent NZ-238276-A (NZ)
Title: Valve apparatus with diaphragm between rotatable body with wing and chamber
Inventor: OLOFSSON HANS KRISTOFFER
IPC: F16K5/18
Filed: 1991-05-27
Abstract: PCT No. PCT/SE91/00359 Sec. 371 Date Oct. 15, 1992 Sec. 102(e) Date Oct. 15, 1992 PCT Filed May 21, 1991 PCT Pub. No. WO91/19123 PCT Pub. Date Dec. 12, 1991.A valve apparatus comprises at least one valve device having a chamber, an inlet and an outlet. A moveable member in the chamber is arranged to displace a membrane such that the membrane is rolled against the wall of the chamber between a closing position at which the membrane covers the opening of the outlet and an opening position at which the opening of the outlet is uncovered. A flow passage is formed for a fluid to flow from the inlet to the outlet. The moveable member is provided with an entrainment member arranged to extend into and be displaced in the flow passage during at least a substantial part of the displacement of the membrane between closing and opening positions.
Patent NZ-266093-A (NZ)
Title: Treating tissue paper with a tri-component biodegradable softener composition of softeners, surfactant compatabilizers and polyhydroxy compounds
Inventor: PHAN DEAN VAN
IPC: D21H19/24
Filed: 1994-04-29
Abstract: A process for making tissue papers, in particular pattern densified tissue papers, having an enhanced tactile sense of softness when treated with tri-component biodegradable softener compositions are disclosed. These tri-component softener compositions comprise nonionic softeners, nonionic surfactant compatibilizers and polyhydroxy compounds. The weight ratio of the nonionic softeners to the nonionic surfactant compatibilizers ranges typically from about 10:1 to 1:10. The weight ratio of the nonionic softeners to the polyhydroxy compounds ranges typically from about 10:1 to 1:10. The tri-component biodegradable softeners are typically applied from an aqueous dispersion to at least one surface of the dry tissue paper web.
Patent NZ-279954-A (NZ)
Title: Lipophilic carrier preparation comprising a galacto-lipid material at least 50% of which comprises digalactosyldiacylglycerols
Inventor: CARLSSON ANDERS
IPC: A23L35/00
Filed: 1995-02-06
Abstract: PCT No. PCT/SE95/00117 Sec. 371 Date Jul. 15, 1996 Sec. 102(e) Date Jul. 15, 1996 PCT Filed Feb. 6, 1995 PCT Pub. No. WO95/20945 PCT Pub. Date Aug. 10, 1995The invention relates to a lipophilic carrier preparation having a continuous lipid phase, comprising a polar lipid material in combination with a non-polar lipid, and optionally a polar solvent, wherein the polar lipid material is a galacto-lipid material. The invention also relates to the use of said lipophilic carrier preparation as a carrier for an active substance in a pharmaceutical composition, but also in nutritional, cosmetical and food products, as well as to a pharmaceutical composition. The invention relates to a lipophilic carrier preparation having a continuous lipid phase, comprising a polar lipid material in combination with a non-polar lipid, and optionally a polar solvent, wherein the polar lipid material is a galactolipid material. The invention also relates to the use of said lipophilic carrier preparation as a carrier for an active substance in a pharmaceutical composition, but also in nutritional, cosmetic and food products, as well as to a pharmaceutical composition.
Patent NZ-282557-A (NZ)
Title: Ultrasonic delivery system for therapeutic use
Inventor: RYABY JOHN P
IPC: A61B17/22
Filed: 1995-03-02
Abstract: This invention relates to apparatus for providing and using a gel containment structure with an ultrasonic delivery system. The apparatus includes a special bladder (10), a cap or another enclosure means for positioning adjacent the transmitting surface (22) so that the coupling gel is retained adjacent the transmitting surface (22). <IMAGE>
Patent NZ-297718-A (NZ)
Title: Three dimensional imaging by variation of focus within pixel area
Inventor: ZELITT SHELDON S
IPC: G02B27/22
Filed: 1995-12-28
Abstract: A 3-dimensional image is obtained from a 2-dimensional display by varying the apparent distance of the image from the viewer on a pixel by pixel basis. The apparent visual distance of the associated pixel from the viewer is achieved in a television system by controlling the electron beam to move a minute distance vertically as it scans horizontally. The vertical distance is determined by a depth component incorporated in the broadcast signal received by a television set. Specifically there is provided a method of encoding a television broadcast signal comprising the steps of generating a depth signal for each pixel and adding the depth signal as a component of the broadcast signal.
Patent NZ-298554-A (NZ)
Title: A tumour suppressor gene (Hypermethylated in Cancer) HIC-1 and its use
Inventor: BAYLIN STEPHEN B
IPC: A61P15/00
Filed: 1995-11-15
Abstract: olynucleotide and polypeptide sequences encoding a novel tumor suppressor, HIC-1, are provided. Also included is a method for detecting a cell proliferative disorder associated with HIC-1. HIC-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders.  Divisional filed as 501892
Patent NZ-299778-A (NZ)
Title: Process for the bioconversion of elemental sulphur into a sulphide using a micro-organism and a reducing sugar and for producing a flavouring agent from the reaction medium
Inventor: CERNY CHRISTOPH
IPC: A23L27/21
Filed: 1996-11-19
Abstract: Conversion of elementary sulphur to sulphide comprises incubating a microorganism which is suitable for use in food with the sulphur in the presence of a reducing sugar. Also claimed are:(a) a human or animal food containing the sulphide, and(b) the use of a reaction medium containing the flavouring agent or its reactive precursor, in a mixture with other materials rich in precursors and/or flavour reinforcers, especially soy sauce, yeast autolysate, sodium chloride, sugars, fats and flavourings.
Patent NZ-314735-A (NZ)
Title: Communicating on and monitoring of electric fence wiring systems using a pulse density modulated signal
Inventor: ADAMSON PAUL ROBERT
IPC: A01K3/00
Filed: 1998-04-30
Abstract: Signals are sent along an electric fence wire by pulse density modulation.  The signals may be used for communication between a master unit and slave units for monitoring the condition of the fence.  The transmissions from different slave units are timed to occur at different times or timeslots between successive pulses from the energiser.  The slave units are powered from the electric fence pulses.  The slave units monitor the and sum up the peak voltages of energy pulses until a threshold value is reached at which point a response signal is sent to the master unit.  The master unit determines how many times each slave unit has responded within a known number of fence pulses, and can then determine the peak voltage on the fence at each slave unit to enable the condition of the fence to be determined.
Patent NZ-332634-A (NZ)
Title: Isolated autophosphorylating polypeptide having phosphoinositide-3-kinase activity
Inventor: VANHASEBROECK BART
IPC: A61K48/00
Filed: 1997-05-30
Abstract: The isolated autophosphorylating polypeptide or a fragment thereof possessing P13 kinase activity has the amino acid sequence depicted in figure 1 of the specification or a homologue thereof optionally modified by deletion, substitution or addition of at least one amino acid residue and characterized in that the polypeptide is selectively expressed in white blood cells and/or melanomas. An antibody, nucleic acid encoding the above polypeptide and host cell thereof are disclosed. A pharmaceutical/veterinary composition thereof is useful for treating cancer.
Patent NZ-334337-A (NZ)
Title: Inhalation flow meter in combination with restriction device that is removable, adjustable or able to be made inoperative
Inventor: GILLINGS ROBERT
IPC: A61B5/097
Filed: 1999-02-22
Abstract: Adaptor 40 has a restriction and is coupled to a peak flow inhalation meter.  The adaptor may be removable and can be replaced with adjustable restrictors or the restriction can be made inoperative.
Patent NZ-334496-A (NZ)
Title: Serum cholesterol lowering composition of sitostanol and campestanol fatty acid esters for addition to fat-containing foods
Inventor: WESTER INGMAR
IPC: A23D7/00
Filed: 1996-09-02
Abstract: The composition comprises sitostanol fatty acid esters and at least 10% by weight of a campestanol fatty acid ester. The composition can be used to lower serum cholesterol levels when incorporated into edible commodities such as cooking oils, margarines, butter, mayonnaise, salad dressings, shortenings or cheeses.   The weight ratio of campestanol fatty acid ester to sitostanol fatty acid ester in the composition added to food substances is from 1:9 to 4:6.
Patent NZ-335421-A (NZ)
Title: Insecticidal compositions and methods
Inventor: EARLEY FERGUS GERARD PAUL
IPC: A01N43/38
Filed: 1997-11-06
Abstract: An insecticidal composition is disclosed comprising a first insecticidally active ingredient, to which insect pests have developed a degree of resistance, an insecticidally inert carrier or diluent and, optionally, one or more surface active agents, characterised in that the composition further contains a sufficient amount of a compound of formula (I), wherein A represents a bidentate group of formula -CH2CH2- or CH=CH; Ar is phenyl, pyridinyl, pyridazinyl or pyrazinyl, all being optionally substituted with halogen, C1-4 alkyl, C1-4 alkoxy, C2-4 alkenyl, C2-4 alkynyl or cyano; R is hydrogen, C1-4 alkyl (optionally substituted with cyano, CO2(C1-4 alkyl) or phenyl (itself optionally substituted with halogen, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl or C1-4 haloalkoxy)), C2-4 haloalkyl (the 'alpha'-carbon being unsubstituted), C3-4 alkenyl or C3-4 alkynyl; provided that when R is alkenyl or alkynyl said group does not have an unsaturated carbon atom bonding directly to the ring nitrogen of formula (I); or an acid addition salt, quaternary ammonium salt or N-oxide derived therefrom; to boost the activity of the composition to overcome the resistance of the insect pests; and a method of using such a composition to combat insect pests.
Patent NZ-337832-A (NZ)
Title: A bag with a block base and related methods of forming and filling thereof
Inventor: ROSS KEITH NEIL
IPC: B65D30/10
Filed: 1999-09-15
Abstract: Front and back panels of the bag are joined by a gusset form. The bottom of the bag is closed by sealing front and back panels to each other and/or to an adjacent ply of the gusset form. At or towards mouth edges at least one of the front or back panels is sealed (at 12) to an adjacent ply of the gusset form to provide a clamp engagement region to allow filler clamps to hold the bag for filling.
Patent NZ-502278-A (NZ)
Title: Gamma-linolenic acid and thioctic acid for treating diabetes
Inventor: HORROBIN DAVID FREDERICK
IPC: A23L33/00
Filed: 1998-07-22
Abstract: The use of biocompatible disulphide and essential fatty acid for treating or prevention of diabetes, insulin resistance or the complications of diabetes. The biocompatible disulphide is a TA (thioctic acid) or related compound and suitable essential fatty acids is one beyond the 6-desaturation step in the n-6 and n-3 metabolic pathways.